Navigation Links
Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2008 Results
Date:3/12/2009

NANJING, China, March 12 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ("Simcere" or the "Company') (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today reported unaudited financial results for the quarter and fiscal year ended December 31, 2008.

    Highlights

    -- Total revenue increased to RMB 466.9 million (US$68.4 million) for the
       fourth quarter of 2008, representing 17.1% year-over-year growth; for
       the full year of 2008, total revenue was RMB 1,741.1 million (US$255.2
       million), an increase of 27.2% from RMB 1,368.7 million for the full
       year of 2007;
    -- Income from operations was RMB 72.7 million (US$10.6 million) for the
       fourth quarter of 2008, compared to RMB 73.2 million for the
       corresponding period in 2007. For the full year of 2008, operating
       income was RMB 357.0 million (US$52.3 million), an increase of 35.3%
       from RMB 263.9 million for the full year of 2007;
    -- Net income was RMB 51.7 million (US$7.6 million) for the fourth quarter
       of 2008, representing 33.8% year-over-year decrease; for the full year
       of 2008, net income was RMB 350.2 million (US$ 51.3 million), an
       increase of 16.2% from RMB 301.3 million for the full year of 2007;
    -- Gross margin for the fourth quarter of 2008 increased to 83.1%,
       compared to 82.2% for the corresponding period in 2007. For the full
       year of 2008, gross margin was 81.6%, compared to 82.4% in 2007.

Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere Pharmaceutical Group, commented: "We are pleased that Simcere achieved overall steady growth in 2008. While the sales growth of Endu has remained below our expectations, both Bicun and Y
'/>"/>

SOURCE Simcere Pharmaceutical Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009
2. Simcere Pharmaceutical Group Announces Preliminary Full Year Revenue and Earnings
3. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
4. Simcere Pharmaceutical Group Reports Unaudited Third Quarter 2008 Results and Announces Share Repurchase
5. Simcere Pharmaceutical Group to Announce Third Quarter 2008 Earnings on Thursday, November 6, 2008
6. Simcere Pharmaceutical Group Announces Two Senior Promotions and Appointment of New Vice President of Human Resources
7. Simcere Pharmaceutical Group to Announce Second Quarter 2008 Earnings on Tuesday, August 5, 2008
8. Simcere Pharmaceutical Group to Participate in Upcoming Investor Conferences in New York
9. Simcere Pharmaceutical Group to Participate in Credit Suisse 3rd Annual Healthcare Trip
10. Simcere Pharmaceutical Group Reports Proposed Private Sale of Ordinary Shares by Existing Shareholder
11. Simcere Pharmaceutical Group Announces the Appointment of New Vice President of Marketing and Two Senior Promotions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Chicago, IL (PRWEB) July 31, 2014 ... wave of automation across the U.S., increasing unemployment, ... middle class. It is a Catch 22—we ... internationally, but this means fewer jobs,” says economist ... the just-released Pollina Corporate Top 10 Pro-Business States ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The Kidney Cancer ... of its monthly news magazine, Kidney Cancer News. , ... presence on a website maintained by an international news organization. ... immediate increase in viewers.” , This month’s program highlights news ... tumors analyzed in a recent study. Kidney Cancer News ...
(Date:7/30/2014)... 30, 2014 Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... highlights for the quarter ended June 30, 2014 on ... close. Regulus will host a conference ... 5:00 pm Eastern Daylight Time to discuss its second ...
(Date:7/30/2014)... 30, 2014  Decision Resources Group finds that ... in the United States ... penetration will be the level of savings achievable ... expected lower cost to patients. Payers plan to ... their pricing expectations in order to encourage physician ...
Breaking Biology Technology:ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3
... 7, 2011 Cellectis (Alternext: ALCLS), the ... its nuclease production capacity has increased ten-fold ... of the nuclease manufacturing gives Cellectis bioresearch, ... of Cellectis, the potential to supply the ...
... , Inc. ( www.sermo.com ), the largest online physician ... of Sermo Sponsorship, a portfolio of offerings that provides ... to engage physicians and educate them on new products ... and mobile platforms, where physicians across 68 specialties discuss ...
... Sanford Rose Associates® - San Diego, focusing exclusively on assignments ... another successful placement. Mr. John Sperzel has been selected for ... a global provider of Point of Care testing systems and ... Directors. Mr. Sperzel is a dynamic business leader ...
Cached Biology Technology:Cellectis Announces a Ten-Fold Increase in Nuclease Production Capacity in 2011 2Sermo, Inc. Introduces New Sponsorship Product for Pharma, Biotech and Life Sciences 2Sermo, Inc. Introduces New Sponsorship Product for Pharma, Biotech and Life Sciences 3John Sperzel Appointed as Chief Executive Officer of ITC Nexus Dx 2
(Date:7/31/2014)... are the largest minority group in the United States, ... Latinos are obese and are 1.2 times as likely ... NYU College of Nursing student researcher Lauren Gerchow, BSN, ... that contribute to this problem by compiling a systematic ... in Latina women recently published in Nursing Research ...
(Date:7/31/2014)... study (HPV-023; NCT00518336) shows the sustained efficacy, ... virus (HPV) vaccine Cervarix. Women vaccinated with ... more than nine years, and vaccine efficacy ... is the longest follow-up report for a ... for the full paper. , HPV ...
(Date:7/31/2014)... team of scientists from Spain, France, and the ... that is the oldest definitive member of the ... amber. The discovery and description were made possible ... synchrotron imaging technique, which allows the detailed study ... new species is described in the journal ...
Breaking Biology News(10 mins):NYU research looks to combat US Latina immigrant obesity 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3
... in spite of waves that sometimes pound the shore ... 600 miles per hour are more prone to snap ... the American Association for the Advancement of Science meeting in ... reported that the fibrous threads she calls "nature,s bungee cords" ...
... or impacted wisdom teeth? As we humans evolved ... brains and shorter jaws, bear big babies and live longer, ... becoming the world,s most successful primate, at nearly 7 billion ... help us better deal with issues from obesity to difficult ...
... the University of Huddersfield aims to ensure that the risk of ... lead plumbing is reduced even further in line with new ... The project is being conducted in collaboration with Yorkshire ... such as European nations and the USA, have similar issues with ...
Cached Biology News:Mussels cramped by environmental factors 2Mussels cramped by environmental factors 3Is there a Neanderthal in the house? 2Research with Yorkshire Water to reduce lead in water supplies 2
Applications: (+) Immunocytochemistry and immunohistochemistry...
For the quantitative determination of canine Interferon gamma,(IFN-γ) concentrations in cell culture supernates, serum and,plasma....
Non-Protein Peroxidase Stabilizer , 1 L...
... Lysate contains the cellular components necessary for ... elongation and termination factors) but has not ... is used primarily for the isolation of ... of endogenous globin mRNA. Untreated Lysate is ...
Biology Products: